LABORATORY RESEARCH Multivalent Peptidomimetic Conjugates: A Versatile Platform for Modulating Androgen Receptor Activity Scientists identified a linear and a cyclic conjugate that exhibits potent anti-proliferative activity in LNCaP-abl cells, a model of therapy-resistant prostate cancer.[J Am Chem Soc] Abstract ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-Like Features Researchers showed that the endogenously expressed ETS transcription factor ESE3/EHF controls prostate epithelial cell differentiation and stem-like potential. [Cancer Res] Abstract Androgen-Regulated Processing of the Oncomir MiR-27a, which Targets Prohibitin in Prostate Cancer Scientists demonstrated that microRNA-27a (miR-27a) is an androgen-regulated oncomir in prostate cancer, acting via targeting the tumor suppressor and androgen receptor corepressor, Prohibitin. [Hum Mol Genet] Abstract Aloe-Emodin Suppresses Prostate Cancer by Targeting the mTOR Complex 2 Investigators found that mammalian target of rapamycin complex 2 (mTORC2) plays an important role in prostate cancer development and aloe-emodin suppresses prostate cancer progression by targeting mTORC2. [Carcinogenesis] Abstract Prostate Cancer Cells and Bone Stromal Cells Mutually Interact with Each Other through Bone Morphogenetic Protein-Mediated Signals Researchers investigated the roles of bone morphogenetic proteins in the interactions between prostate cancer cells and bone stromal cells. [J Biol Chem] Abstract Modulation of Akt/mTOR Signaling Overcomes Sunitinib Resistance in Renal and Prostate Cancer Cells Scientists demonstrated that phosphatase and tensin homolog (PTEN) expression inversely correlates with sunitinib resistance in renal and prostate cancer cells. Restoration of PTEN expression markedly increases sensitivity of tumor cells to sunitinib both in vitro and in vivo. [Mol Cancer Ther] Abstract Inducible Silencing of Protein Kinase D3 Inhibits Secretion of Tumor-Promoting Factors in Prostate Cancer Using both a stable inducible knockdown cell model and a transient knockdown system employing multiple siRNAs, researchers demonstrated that silencing of endogenous protein kinase D3 significantly reduces prostate cancer cell proliferation, migration, and invasion. [Mol Cancer Ther] Abstract Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer Researchers studied two mithramycin A (MTM-A) analogues, which had been generated by genetically engineering of the MTM-A biosynthetic pathway, and evaluated their activity in human prostate cancer in cell cultures and mouse models. [PLoS One] Abstract Curcumin Attenuates ß-Catenin Signaling in Prostate Cancer Cells through Activation of Protein Kinase D1 Researchers demonstrated that curcumin activates protein kinase D1, resulting in changes in ß-catenin signaling by inhibiting nuclear ß-catenin transcription activity and enhancing the levels of membrane ß-catenin in prostate cancer cells. [PLoS One] Abstract CLINICAL RESEARCH A Switch from GnRH Agonist to GnRH Antagonist in Castration-Resistant Prostate Cancer Patients Leads to a Low Response Rate on PSA Investigators evaluated the impact of a switch from GnRH agonist to antagonist in patients with castration-resistant prostate cancer on PSA and testosterone levels at three months. [World J Urol] Abstract Long-Term Dynamics of Bone Mineral Density during Intermittent Androgen Deprivation for Men with Nonmetastatic, Hormone-Sensitive Prostate Cancer Researchers investigated changes in bone mineral density and fracture risk in men who received intermittent androgen deprivation for nonmetastatic, hormone-sensitive prostate cancer. [J Clin Oncol] Abstract |